These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27048925)

  • 1. Associations between the Brief Memory and Executive Test (BMET), Activities of Daily Living, and Quality of Life in Patients with Cerebral Small Vessel Disease.
    Hollocks MJ; Brookes R; Morris RG; Markus HS
    J Int Neuropsychol Soc; 2016 May; 22(5):561-9. PubMed ID: 27048925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Brief Memory and Executive Test (BMET) for detecting vascular cognitive impairment in small vessel disease: a validation study.
    Brookes RL; Hollocks MJ; Khan U; Morris RG; Markus HS
    BMC Med; 2015 Mar; 13():51. PubMed ID: 25858350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brief Memory and Executive Test: evaluation of a new screening test for cognitive impairment due to small vessel disease.
    Brookes RL; Hannesdottir K; Lawrence R; Morris RG; Markus HS
    Age Ageing; 2012 Mar; 41(2):212-8. PubMed ID: 22267862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brief Screening of Vascular Cognitive Impairment in Patients With Cerebral Autosomal-Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy Without Dementia.
    Brookes RL; Hollocks MJ; Tan RY; Morris RG; Markus HS
    Stroke; 2016 Oct; 47(10):2482-7. PubMed ID: 27625375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of awareness of neuropsychological deficit in cerebral small vessel disease: the relationship with executive and episodic memory functions.
    Brookes RL; Hannesdottir K; Markus HS; Morris RG
    J Neuropsychol; 2013 Mar; 7(1):19-28. PubMed ID: 22697174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Brief Memory and Executive Test (BMET): A cognitive screening tool to detect and differentiate vascular cognitive impairment and Alzheimer's disease.
    Hollocks MJ; Brookes RL; Morris RG; Markus HS
    Int J Geriatr Psychiatry; 2018 Feb; 33(2):e273-e279. PubMed ID: 28881062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of small vessel disease correlates with cortical thinning in Parkinson's disease.
    Foo H; Mak E; Yong TT; Wen MC; Chander RJ; Au WL; Tan L; Kandiah N
    Parkinsonism Relat Disord; 2016 Oct; 31():34-40. PubMed ID: 27397577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic associations of cognitive and motor impairments with functional outcome in covert cerebral small vessel disease.
    Jokinen H; Laakso HM; Ahlström M; Arola A; Lempiäinen J; Pitkänen J; Paajanen T; Sikkes SAM; Koikkalainen J; Lötjönen J; Korvenoja A; Erkinjuntti T; Melkas S
    Eur J Neurol; 2022 Jan; 29(1):158-167. PubMed ID: 34528346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Executive dysfunction, awareness deficits and quality of life in patients with cerebral small vessel disease: a structural equation model.
    Brookes RL; Herbert V; Paul S; Hannesdottir K; Markus HS; Morris RG
    Neuropsychology; 2014 Mar; 28(2):247-253. PubMed ID: 24274025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between 2 Measures of Cognitive Instrumental Activities of Daily Living and Their Relation to the Montreal Cognitive Assessment in Persons With Stroke.
    Toglia J; Askin G; Gerber LM; Taub MC; Mastrogiovanni AR; O'Dell MW
    Arch Phys Med Rehabil; 2017 Nov; 98(11):2280-2287. PubMed ID: 28478128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral small vessel disease, medial temporal lobe atrophy and cognitive status in patients with ischaemic stroke and transient ischaemic attack.
    Arba F; Quinn T; Hankey GJ; Ali M; Lees KR; Inzitari D;
    Eur J Neurol; 2017 Feb; 24(2):276-282. PubMed ID: 27862654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impact of cerebral microbleeds in patients with symptomatic small vessel disease.
    Nannoni S; Ohlmeier L; Brown RB; Morris RG; MacKinnon AD; Markus HS;
    Int J Stroke; 2022 Apr; 17(4):415-424. PubMed ID: 33877017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of small vessel disease on motor and cognitive function in Parkinson's disease.
    Shibata K; Sugiura M; Nishimura Y; Sakura H
    Clin Neurol Neurosurg; 2019 Jul; 182():58-62. PubMed ID: 31078957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The INECO Frontal Screening for the Evaluation of Executive Dysfunction in Cerebral Small Vessel Disease: Evidence from Quantitative MRI in a CADASIL Cohort from Colombia.
    Schoemaker D; Zuluaga Y; Viswanathan A; Shrimer D; Torrico-Teave H; Velilla L; Ospina C; Ospina GG; Lopera F; Arboleda-Velasquez JF; Quiroz YT
    J Int Neuropsychol Soc; 2020 Nov; 26(10):1006-1018. PubMed ID: 32487276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychiatric symptoms are associated with exacerbated cognitive impairment in covert cerebral small vessel disease.
    Arola A; Levänen T; Laakso HM; Pitkänen J; Koikkalainen J; Lötjönen J; Korvenoja A; Erkinjuntti T; Melkas S; Jokinen H
    J Int Neuropsychol Soc; 2023 Jun; 29(5):431-438. PubMed ID: 36039945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment and depression in the early 60s: which is more problematic in terms of instrumental activities of daily living?
    Park B; Jun JK; Park J
    Geriatr Gerontol Int; 2014 Jan; 14(1):62-70. PubMed ID: 23560396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apathy, but not depression, is associated with executive dysfunction in cerebral small vessel disease.
    Lohner V; Brookes RL; Hollocks MJ; Morris RG; Markus HS
    PLoS One; 2017; 12(5):e0176943. PubMed ID: 28493898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual markers of cerebral small vessel disease and domain-specific quality of life deficits.
    Fernando J; Brown RB; Edwards H; Egle M; Markus HS; Tay J
    Brain Behav; 2021 May; 11(5):e02106. PubMed ID: 33751852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep microbleeds and periventricular white matter disintegrity are independent predictors of attention/executive dysfunction in non-dementia patients with small vessel disease.
    Cao WW; Wang Y; Dong Q; Chen X; Li YS; Zhou Y; Gao L; Deng Y; Xu Q
    Int Psychogeriatr; 2017 May; 29(5):793-803. PubMed ID: 27938433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cumulative effect of small vessel disease lesions is reflected in structural brain networks of memory clinic patients.
    Heinen R; Vlegels N; de Bresser J; Leemans A; Biessels GJ; Reijmer YD;
    Neuroimage Clin; 2018; 19():963-969. PubMed ID: 30003033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.